In summary, our study identified RHCG as a candidate biomarker correlated with HNSCC tumor progression and dismal prognosis, which acted as a tumor suppressor gene by playing a pivotal role in impeding tumorigenicity and metastasis in HNSCC. This evidence concerns the gene RHCG and head and neck squamous cell carcinoma.